Cost-effectiveness of quadrivalent versus trivalent inactivated influenza vaccines for the Portuguese elderly population
D. Tavares, H. Mourino, C. A. Rodriguez, C. M. Saborido
This study evaluates the cost-effectiveness of switching from trivalent to quadrivalent influenza vaccines for the Portuguese elderly, finding QIV is not cost-effective due to higher costs.
bioRxiv · Jan 4, 2022Scientific Communication & Education